Timeline

Tineke Cantaert

Head of Structure

01 Jan 2023

publication

Antibodies as drugs-a Keystone Symposia report.

17 Nov 2022

publication

Evaluation of cutaneous immune response in a controlled human in vivo model of mosquito bites.

25 Oct 2022

publication

Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history.

01 Jan 2022

publication

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

01 Jan 2022

publication

Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis.

01 Aug 2021

publication

Differential levels of IFNα subtypes in autoimmunity and viral infection.

01 Jul 2021

publication

Antibody-independent functions of B cells during viral infections.

04 Jun 2021

publication

Antibody fucosylation predicts disease severity in secondary dengue infection.

18 Dec 2020

publication

Autoantibody Profiling in Plasma of Dengue Virus-Infected Individuals.

01 Sep 2020

project

Understanding protective humoral immunity in asymptomatic dengue-infected individuals

01 Sep 2020

publication

Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia.

23 Jun 2020

publication

TLR2 on blood monocytes senses dengue virus infection and its expression correlates with disease pathogenesis.

01 Jan 2020

publication

Direct Infection of B Cells by Dengue Virus Modulates B Cell Responses in a Cambodian Pediatric Cohort.

01 Jan 2020

publication

Aedes Mosquito Salivary Components and Their Effect on the Immune Response to Arboviruses.

01 Jan 2020

publication

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.

01 Dec 2019

publication

A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.

21 Jun 2019

publication

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice

21 Jan 2019

publication

Time to Micromanage the Pathogen-Host-Vector Interface: Considerations for Vaccine Development.

01 Jan 2019

publication

Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection.

01 Aug 2018

publication

Host genetic control of mosquito-borne Flavivirus infections.

05 May 2018

publication

A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival.

31 Dec 2017

course

10th HKU-Pasteur Immunology Course: December 2-15, 2018

05 Sep 2017

news

Cover page in Science Translational Medicine

30 Aug 2017

publication

Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.

01 Apr 2017

publication

The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation.

01 Nov 2016

publication

Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project.

17 Nov 2015

publication

Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance.

01 Apr 2014

publication

A little guide for advanced search:

Timeline

Antibodies as drugs-a Keystone Symposia report.

Evaluation of cutaneous immune response in a controlled human in vivo model of mosquito bites.

Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history.

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.

Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis.

Differential levels of IFNα subtypes in autoimmunity and viral infection.

Antibody-independent functions of B cells during viral infections.

Antibody fucosylation predicts disease severity in secondary dengue infection.

Autoantibody Profiling in Plasma of Dengue Virus-Infected Individuals.

Understanding protective humoral immunity in asymptomatic dengue-infected individuals

Comparison of dengue case classification schemes and evaluation of biological changes in different dengue clinical patterns in a longitudinal follow-up of hospitalized children in Cambodia.

TLR2 on blood monocytes senses dengue virus infection and its expression correlates with disease pathogenesis.

Direct Infection of B Cells by Dengue Virus Modulates B Cell Responses in a Cambodian Pediatric Cohort.

Aedes Mosquito Salivary Components and Their Effect on the Immune Response to Arboviruses.

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue.

A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice

Time to Micromanage the Pathogen-Host-Vector Interface: Considerations for Vaccine Development.

Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection.

Host genetic control of mosquito-borne Flavivirus infections.

A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival.

10th HKU-Pasteur Immunology Course: December 2-15, 2018

Cover page in Science Translational Medicine

Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.

The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation.

Multi-center harmonization of flow cytometers in the context of the European “PRECISESADS” project.

Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance.

Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.